SV Health Investors
SV Health Investors is a leading venture capital firm focused on investing in innovative healthcare companies. With a mission to transform healthcare one investment at a time, SV Health Investors supports diverse entrepreneurs in creating breakthrough companies and treatments. The firm has a strong track record of investing in companies that improve healthcare through innovative care delivery models, next-generation digital health technologies, and groundbreaking medical products. SV Health Investors is committed to diversity and believes that it strongly contributes to success.
SV Health Investors
71 Kingsway, London, WC2B 6ST, UK
What We Do
SV Health Investors provides capital to healthcare companies across various stages, including seed, growth, and buyout stages.
The firm offers strategic guidance to its portfolio companies, leveraging its extensive experience in healthcare investing and operations.
SV Health Investors provides mentorship to entrepreneurs, helping them navigate the challenges of building successful healthcare companies.
The firm connects its portfolio companies with a network of industry experts, strategic partners, and potential customers.
SV Health Investors offers operational support to its portfolio companies, helping them scale and optimize their operations.
The firm provides access to resources such as industry insights, market research, and regulatory expertise.
Industry Focus
Show LessInvestment Range
Portfolio
Centauri Health Solutions is a portfolio company of SV Health Investors.
#Healthcare
Spectrum Professional Services is a portfolio company of SV Health Investors.
#Healthcare
Schweiger Dermatology is a portfolio company of SV Health Investors.
#Healthcare
Nordic Consulting Partners is a portfolio company of SV Health Investors.
#Healthcare
AeroCare Holdings, Inc. is a portfolio company of SV Health Investors.
#Healthcare
Bicycle Therapeutics is a portfolio company of SV Health Investors.
#Biotechnology
Nitrase Therapeutics is a portfolio company of SV Health Investors.
#Biotechnology
LoQus23 Therapeutics is a portfolio company of SV Health Investors.
#Biotechnology
Caraway Therapeutics is a portfolio company of SV Health Investors.
#Biotechnology
Xilio Therapeutics rebranded from Akrevia Therapeutics and announced a $100.5 million Series B financing.
#Therapeutics
Adimab is a global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies.
#Biotechnology
AdvanCell completed an oversubscribed US$112 million Series C financing to expand its manufacturing capacity and accelerate clinical development of its radionuclide therapies.
#Therapeutics
Alpheus Medical closed $16M in Series A financing for its novel sonodynamic therapy platform targeting solid body cancers.
#Medtech
Nanopath creates diagnostics that test pelvic and gynecologic infections during a single visit, recently closed a Series A funding round of $10 million.
#Medtech
QurAlis received $88 million for two Phase I studies, focusing on ALS therapy development.
#Biotechnology
Amphista Therapeutics is focused on next generation targeted protein degradation (TPD) medicines.
#Therapeutics
CarePredict scored $29 million in Series A-3 investment to accelerate its growth in AI-enabled senior care.
#Medtech
Aligned Telehealth provides telemedicine solutions, including psychiatric specialty physician consultations.
#Healthcare Growth
Key People
Managing Partner, Medtech
Managing Partner, Medtech, Healthcare Growth
MCF Partner, Medtech
Teijin in Residence, Medtech
Venture Partner, Medtech
Executive Assistant, Medtech